Announcement: AMOR ventures to Ireland

Journal to debut itself to the world, and seek more collaboration opportunities

The Irish Association for Cancer Research (IACR) will be holding its 2016 annual meeting next month and the Advances in Modern Oncology Research (AMOR) journal is proud to be the official publishing partner of the event.

IACR is an all-Ireland organization with a mission to promote national and international cancer research collaborations for the ultimate betterment of patients and society, and with continuous strategic representation on the governing council from research institutions from the Republic of Ireland and Northern Ireland (UK) per its official status as a cancer research charity endowed in 1990s.

Its first meetings dated back to 1960s, and previous annual meetings have been held in Limerick (2015), Galway (2014), Dublin (2013) and other beautiful cities in Ireland. In 2016, the IACR meeting will be held on February 25-26 in the historic city of Cork.

The multidisciplinary research meeting seeks to build a vital bridge between basic and translational scientists, researchers earlier in their career and experts in the field. “Importantly, the meeting brings us together to identify the new research areas and collaborators, expanding our understanding of cancer research and importance of networking,” according to Dr. Olga Piskareva, the Honorary Treasurer of IACR, in an interview with AMOR press team.

Such networking efforts will be much furthered with the first-time collaboration between AMOR and IACR, praised Dr. Piskareva.

“The main objectives of the association were, until now, high-level information-sharing and the promotion of collaboration among researchers. Research publishing is one of the major criteria in research as well as a key measure for most funding bodies,” she noted.

“Therefore, proceedings are a new and advanced level of dissemination of the meeting. The proceedings will extend the life of our conference as they will be available in print and online providing great reference tool and research community awareness. Therefore, collaboration with AMOR would bring higher standards to the IACR meeting and strengthen the IACR reputation as a cancer research association. The professional publication support by AMOR will raise the IACR publication standards as well,” said Dr. Piskareva, who hails from the Royal College of Surgeons in Ireland (RSCI), Dublin.

Delegates will have an opportunity to directly engage with AMOR Editorial and get insights on editorial work, the standards of research papers, the paper review process and the technical side of publishing, according to the IACR Honorary Treasurer.

“This collaboration would increase the reach of the upcoming meeting by advertising and promoting it extensively through PiscoMed’s publishing network and among AMOR’s geographically diverse editorial board members. It will help to increase the international presence of IACR, generating new international collaboration and funding opportunities,” Dr. Piskareva said.

Among highlights of the upcoming IACR annual meeting will be oral and poster presentations by post-doctoral fellows and post-graduate scholars, as well as investigators early in their career. Two EACR Young Scientist Awards will be received by the most prominent young cancer researchers (junior and senior postdocs). The IACR will also hold an inaugural career discussion and communication event organized by the Junior Council on Wednesday the 24th Feb, 2016.

The 2016 edition of IACR meeting will focus on cancer research areas of ‘Microbes and Cancer’, ‘Immune based therapies in Cancer’, ‘Targeting Oncogenic Signalling Networks in Cancer’ and ‘The Hallmarks of Cancer: ‘The newbies’ targeting Genetic instability, Epigenetics, Angiogenesis and Metabolism’.

The meeting also plans to publish proceedings, organize a career development session and improve its Poster session. This time the Poster session will be split in two and run over a longer period making it more interactive and competitive. The panel of judges for Poster session will include PIs, representatives from the industry, and AMOR.

“In 2016, we are planning to publish Proceedings of all oral presentations and session speakers. The publishing is one of the major criteria in research as well as a key measure for most funding bodies. Therefore, Proceedings with a dedicated ISBN number is a new and advanced level of dissemination of the meeting,” said Dr. Piskareva.

In a phone interview with AMOR press team, AMOR Editor-in-Chief Dr. Omar Abdel-Rahman expressed his hopes that a collaboration with the IACR will help spread AMOR’s wings.

“The mission and vision of AMOR is to establish a worldwide network of cancer-related researchers who are interested in publishing and distributing effective cancer research and cancer-related treatments,” he said.

“So the collaboration of AMOR as a universal and global platform of cancer research with respectable cancer organization like the Irish Association for Cancer Research and others will further boost and support this mission and vision further,” Dr. Omar continued.

AMOR Managing Editor, TS Jong said, “The IACR meeting is an excellent platform to introduce AMOR to an international audience, especially European and North American researchers, who might not be familiar with our journal. As there are participants from well-known institutions on both sides of the Atlantic, AMOR will benefit significantly from this meeting in terms of developing its brand recognition and engaging its target audience.”

AMOR will play a significant role during the meeting, said Jong. “On the opening day of the meeting, AMOR’s Editor-in-Chief Dr. Omar Abdel-Rahman will be delivering a speech to officially introduce the journal to the participants of the meeting. In addition, we are giving away four prizes (i.e., complete publication fees waiver) to the winners of the European Association of Cancer Research’s Young Scientist Award, as well as the best oral presentations of the meeting upon the conclusion of the event.”

AMOR continues to seek opportunities to increase its brand awareness among international researchers, in hope of attracting high-quality manuscript submissions to the journal, Jong said. “Furthermore, we are also looking for collaboration opportunities with academicians and research institutions worldwide to facilitate our content creation and development programmes. In the long run, we would like to establish AMOR as an impactful and trusted open access source of information for oncology research,” he concluded.